Prevention of VTE in Nonsurgical Patients

2012/02/01 by Susan R. Kahn, Wendy Lim, Andrew S. Dunn +11 · 12 citations
Engineering · Medicine · #Anesthesia #Antithrombotic #Apixaban #Atrial fibrillation #Dabigatran #Deep vein #Fondaparinux #Guideline #Heparin-Induced Thrombocytopenia and Thrombosis #Intermittent pneumatic compression #Internal medicine #Low molecular weight heparin #Mechanical Circulatory Support Devices #Medicine #Orthopedic surgery #Pulmonary embolism #Rivaroxaban #Surgery #Thrombosis #Venous Thromboembolism Diagnosis and Management #Venous thromboembolism #Vitamin K antagonist #Warfarin

paper · pdf · doi:10.1378/chest.11-2296

crossref issued 2012/02/01 · crossref published 2012/02/01 · crossref published-print 2012/02/01 · openalex publication_date 2012/02/01 · crossref created 2012/02/07 · openalex created_date 2016/06/24 · crossref deposited 2023/06/14 · crossref indexed 2026/07/10 · openalex updated_date 2026/08/01

Citations

• A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score
• Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II)
• Development and validation of a predictive model for chemotherapy-associated thrombosis
• Prevention of Venous Thromboembolism
• Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease
• Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
• Risk factors for venous thrombosis – current understanding from an epidemiological point of view
• Relative Impact of Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism
• Thromboembolism in Hospitalized Neutropenic Cancer Patients
• Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin Extended Out-of-Hospital vs In-Hospital Warfarin/Out-of-Hospital Placebo in Hip Arthroplasty Patients
• VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
• Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients
• Prevention of VTE in Orthopedic Surgery Patients

Cited by

• Executive Summary
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
• VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock
• Antithrombotic Therapy for VTE Disease
• Antithrombotic Therapy for VTE Disease
• Call to Action to Prevent Venous Thromboembolism in Hospitalized Patients: A Policy Statement From the American Heart Association
• American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
• American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
• Venous thromboembolism prophylaxis using the Caprini score
• Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
• Prevention of VTE in Nonorthopedic Surgical Patients
• Deep vein thrombosis [wikipedia]